483 Aurobindo Pharma (Unit III) Apr 2017

483 Aurobindo Pharma (Unit III) Apr 2017

Cheryl Clausen FDA, Angela Glenn FDA$119.00 - Available Now

FDA investigators audited the Aurobindo Pharma (Unit III) - Medchal, India facility and issued inspectional observations (via FDA 483) on 18 Apr 2017.

Product details

  • Category: Human Drugs
  • Inspection end: 18 Apr 2017
  • Location: Medchal, India
  • FEI: 3004021229
Add To Cart